Sensorium Therapeutics
Stephen is an Associate Professor of Neurology at Harvard Medical School, an Associate Neuroscientist at Massachusetts General Hospital (MGH), Director of the MGH Chemical Neurobiology Laboratory within the Center for Genomic Medicine and Scientific Director of Neurobiology for the MGH Center for the Neuroscience of Psychedelics. Dr. Haggarty is also a Senior Associate Member of the Broad Institute, an Affiliate Faculty Member of the Harvard Stem Cell Institute, and he was named the Stuart & Suzanne Steele MGH Research Scholar in 2017. Dr. Haggarty completed his PhD in the Department of Chemistry & Chemical Biology at Harvard University, and joined the faculty of Harvard Medical School/MGH in 2006. With a background in the discovery and characterization of natural products and natural product-inspired molecules, Dr. Haggarty’s research program operates at the interface of psychiatry and neurology with a focus on dissecting the role of neuroplasticity and resiliency in health and disease. A major emphasis of his research group is the use of reprogramming technology to create patient-specific, induced pluripotent stem cells (iPSCs) as ex vivo models that provide powerful new avenues for studies of neuroplasticity, to investigate the mechanism of action of existing psychoactive molecules, and in the future to potentially discover next- generation agents with improved efficacy to advance the field of precision medicine.
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.